What is MICROCHIP TECHNOLOGY INC.'s earnings per share (EPS)?

MICROCHIP TECHNOLOGY INC. (MCHPP) reported diluted earnings per share of $0.22 for fiscal year 2026. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

MICROCHIP TECHNOLOGY INC. (MCHPP) Financials

MCHPP

Trailing 12 months to June 30, 2026

Revenue $5.1B +20.9% YoY

Net Income $478.4M +422.4% YoY

EPS (Diluted) $0.68 +300.0% YoY

Free Cash Flow $1.1B +53.1% YoY

Source SEC Filings (10-K/10-Q) Latest period Q1 FY2027, ended Jun 30, 2026 Reported Aug 6, 2026 Currency USD FYE March

Newest figures come from the 10-Q for Q1 FY2027, filed Aug 6, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the MCHPP SEC filings page.

MICROCHIP TECHNOLOGY INC. (MCHPP) reported $5.1B in revenue over the twelve months to Jun 30, 2026, up 20.9% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI MCHPP FY2026 2026-08-29

A revenue shock left a research-intensive business with partial earnings recovery, strong cash conversion, and dividends exceeding current net income.

Cash conversion is stronger than reported profitability in FY2026: operating cash flow was $962M versus net income of $230M. Free cash flow of $871M after $91M of capital expenditure means most operating cash remained after recorded reinvestment, despite the modest earnings base.

The FY2025 revenue contraction was not followed by a full operating reset: revenue moved from $4.4B to $4.7B in FY2026, while operating margin improved from 6.7% to 10.4%. That margin remains far below FY2024’s 33.7%, so profitability recovered faster than volume but not yet its prior structure.

The business continues to fund substantial research spending: FY2026 R&D was $1.1B, more than twice operating income of $490M; development spending is therefore a major determinant of operating profit. Distributions exceeded current earnings: dividends were $984M versus $230M of net income.

Financial Health Signals

Financial health score not available

MICROCHIP TECHNOLOGY INC. does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Piotroski F-Score Neutral

6/9

MICROCHIP TECHNOLOGY INC. passes 6 of 9 financial strength tests. All 4 profitability signals pass (positive income, cash flow, and earnings quality), no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), both operating efficiency signals pass.

Earnings Quality Cash-Backed

4.18x

For every $1 of reported earnings, MICROCHIP TECHNOLOGY INC. generates $4.18 in operating cash flow ($962.1M OCF vs $230.0M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage Adequate

2.21x

MICROCHIP TECHNOLOGY INC. earns $2.21 in operating income for every $1 of interest expense ($490.1M vs $221.3M). This adequate coverage means the company can meet its interest obligations, but has limited cushion if earnings fall.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$1.5B

YoY+38.0%

QoQ+13.2%

5Y CAGR-1.1%

10Y CAGR+6.4%

MICROCHIP TECHNOLOGY INC. generated $1.5B in revenue in Q1 2027. This represents an increase of 38.0% from the same quarter a year earlier. Against the prior quarter it is up 13.2%.

EBITDA

$493.5M

YoY+142.9%

QoQ+26.2%

5Y CAGR-5.1%

10Y CAGR+24.8%

MICROCHIP TECHNOLOGY INC.'s EBITDA was $493.5M in Q1 2027, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 142.9% from the same quarter a year earlier. Against the prior quarter it is up 26.2%.

Net Income

$229.8M

YoY+1335.5%

QoQ+59.4%

5Y CAGR-1.9%

MICROCHIP TECHNOLOGY INC. reported $229.8M in net income in Q1 2027. This represents an increase of 1335.5% from the same quarter a year earlier. Against the prior quarter it is up 59.4%.

EPS (Diluted)

$0.37

QoQ+68.2%

5Y CAGR-3.8%

MICROCHIP TECHNOLOGY INC. earned $0.37 per diluted share (EPS) in Q1 2027. Against the prior quarter it is up 68.2%.

Cash & Balance Sheet

Free Cash Flow

$497.6M

YoY+93.1%

QoQ+104.9%

5Y CAGR-1.8%

10Y CAGR+8.3%

MICROCHIP TECHNOLOGY INC. generated $497.6M in free cash flow in Q1 2027, representing cash available after capex. This represents an increase of 93.1% from the same quarter a year earlier. Against the prior quarter it is up 104.9%.

Cash & Debt

$272.3M

YoY-51.9%

QoQ+13.3%

5Y CAGR-0.4%

10Y CAGR-7.6%

MICROCHIP TECHNOLOGY INC. held $272.3M in cash against $5.4B in long-term debt as of Q1 2027.

Dividends Per Share

$0.46

QoQ0.0%

5Y CAGR+17.1%

10Y CAGR+2.4%

MICROCHIP TECHNOLOGY INC. paid $0.46 per share in dividends in Q1 2027. It is unchanged from the prior quarter.

Shares Outstanding

543M

QoQ+0.2%

5Y CAGR+14.7%

10Y CAGR+9.7%

MICROCHIP TECHNOLOGY INC. had 543M shares outstanding in Q1 2027. Against the prior quarter it is up 0.2%.

Margins & Returns

Gross Margin

63.2%

YoY+9.6pp

QoQ+2.3pp

5Y CAGR-1.0pp

10Y CAGR+19.6pp

MICROCHIP TECHNOLOGY INC.'s gross margin was 63.2% in Q1 2027, indicating the percentage of revenue retained after direct costs. This is up 9.6 percentage points from the same quarter a year earlier. Against the prior quarter it is up 2.3 percentage points.

Operating Margin

22.7%

YoY+19.7pp

QoQ+6.1pp

5Y CAGR-0.8pp

10Y CAGR+30.1pp

MICROCHIP TECHNOLOGY INC.'s operating margin was 22.7% in Q1 2027, reflecting core business profitability. This is up 19.7 percentage points from the same quarter a year earlier. Against the prior quarter it is up 6.1 percentage points.

Net Margin

15.5%

YoY+17.2pp

QoQ+4.5pp

5Y CAGR-0.6pp

10Y CAGR+29.7pp

MICROCHIP TECHNOLOGY INC.'s net profit margin was 15.5% in Q1 2027, showing the share of revenue converted to profit. This is up 17.2 percentage points from the same quarter a year earlier. Against the prior quarter it is up 4.5 percentage points.

Return on Equity

3.6%

YoY+3.8pp

QoQ+1.3pp

5Y CAGR-1.0pp

10Y CAGR+8.0pp

MICROCHIP TECHNOLOGY INC.'s ROE was 3.6% in Q1 2027, measuring profit generated per dollar of shareholder equity. This is up 3.8 percentage points from the same quarter a year earlier. Against the prior quarter it is up 1.3 percentage points.

Capital Allocation

R&D Spending

$308.9M

YoY+20.9%

QoQ+5.1%

5Y CAGR+5.3%

MICROCHIP TECHNOLOGY INC. invested $308.9M in research and development in Q1 2027. This represents an increase of 20.9% from the same quarter a year earlier. Against the prior quarter it is up 5.1%.

Capital Expenditures

$13.9M

YoY-22.3%

QoQ-2.1%

5Y CAGR-30.6%

10Y CAGR+33.6%

MICROCHIP TECHNOLOGY INC. invested $13.9M in capex in Q1 2027, funding long-term assets and infrastructure. This represents a decrease of 22.3% from the same quarter a year earlier. Against the prior quarter it is down 2.1%.

Share Buybacks

Not reported for Q1 2027.

MCHPP Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

MCHPP quarterly income statement

Metric	TTM	FY2610-K	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K
Revenue	$5.1B	$4.7B+7.1%	$4.4B-42.3%	$7.6B-9.5%	$8.4B+23.7%	$6.8B+25.4%	$5.4B+3.1%	$5.3B-1.4%	$5.3B+34.4%	$4.0B+16.8%	$3.4B+56.8%	$2.2B+1.2%	$2.1B+11.2%	$1.9B+22.1%	$1.6B+14.3%	$1.4B
Cost of Revenue	$2.0B	$2.0B+3.0%	$1.9B-26.7%	$2.6B-3.7%	$2.7B+15.6%	$2.4B+15.1%	$2.1B+1.4%	$2.0B-16.0%	$2.4B+55.0%	$1.6B-5.5%	$1.7B+70.6%	$967.8M+5.5%	$917.5M+14.3%	$802.5M+8.0%	$743.2M+25.8%	$590.8M
Gross Profit	$3.1B	$2.7B+10.3%	$2.5B-50.6%	$5.0B-12.3%	$5.7B+28.1%	$4.4B+31.7%	$3.4B+4.2%	$3.2B+10.6%	$2.9B+21.1%	$2.4B+37.8%	$1.8B+45.8%	$1.2B-2.0%	$1.2B+8.9%	$1.1B+34.6%	$838.5M+4.9%	$799.3M
R&D Expenses	$1.1B	$1.1B+10.4%	$983.8M-10.4%	$1.1B-1.9%	$1.1B+13.1%	$989.1M+18.3%	$836.4M-4.7%	$877.8M+6.2%	$826.3M+56.1%	$529.3M-2.9%	$545.3M+46.3%	$372.6M+6.6%	$349.5M+14.6%	$305.0M+19.8%	$254.7M+39.5%	$182.7M
SG&A Expenses	$699.3M	$674.3M+9.2%	$617.7M-15.9%	$734.2M-8.0%	$797.7M+11.0%	$718.9M+17.8%	$610.3M-9.8%	$676.6M-0.9%	$682.9M+51.1%	$452.1M-9.5%	$499.8M+65.7%	$301.7M+9.8%	$274.8M+2.8%	$267.3M+2.2%	$261.5M+25.5%	$208.3M
Operating Income	$794.8M	$490.1M+65.4%	$296.3M-88.5%	$2.6B-17.5%	$3.1B+68.5%	$1.8B+85.3%	$998.1M+54.2%	$647.1M-9.4%	$714.3M-23.7%	$936.3M+239.5%	$275.8M-21.7%	$352.3M-17.2%	$425.6M-7.2%	$458.9M+157.0%	$178.6M-55.0%	$396.5M
EBITDA	N/A	$1.2B+12.7%	$1.0B-69.7%	$3.5B-16.1%	$4.1B+37.5%	$3.0B+39.1%	$2.2B+15.5%	$1.9B+17.1%	$1.6B+2.5%	$1.6B+108.3%	$745.0M+17.2%	$635.5M-9.7%	$703.9M+8.6%	$648.0M+69.3%	$382.6M-22.8%	$495.9M
Interest Expense	$212.7M	$221.3M-14.6%	$259.2M+30.7%	$198.3M-2.7%	$203.9M-20.7%	$257.0M-28.0%	$356.9M-28.2%	$497.3M-1.1%	$502.9M+152.7%	$199.0M+36.0%	$146.3M+40.7%	$104.0M+67.6%	$62.0M+27.3%	$48.7M+19.1%	$40.9M+19.4%	$34.3M
Income Tax	$100.8M	$43.5M+10.4%	$39.4M-91.4%	$459.0M-31.7%	$672.0M+241.1%	$197.0M+2089.9%	-$9.9M+97.6%	-$420.2M-177.5%	-$151.4M-131.4%	$481.9M+696.4%	-$80.8M-89.7%	-$42.6M-119.4%	-$19.4M-152.4%	$37.1M+49.6%	$24.8M-42.3%	$43.0M
Net Income	$478.4M	$230.0M+46100.0%	-$500K-100.0%	$1.9B-14.8%	$2.2B+74.1%	$1.3B+267.9%	$349.4M-38.8%	$570.6M+60.3%	$355.9M+39.4%	$255.4M+55.2%	$164.6M-49.2%	$324.1M-12.2%	$369.0M-6.6%	$395.3M+210.3%	$127.4M-62.2%	$336.7M
EPS (Basic)	N/A	$0.22+2300.0%	-$0.01-100.3%	$3.52-13.5%	$4.07+74.7%	$2.33+247.8%	$0.67-43.7%	$1.19-21.2%	$1.51+37.3%	$1.10+44.7%	$0.76-52.2%	$1.59-13.6%	$1.84-7.5%	$1.99+206.2%	$0.65-63.1%	$1.76
EPS (Diluted)	$0.68	$0.22	-$0.01	$3.48-13.4%	$4.02+77.1%	$2.27	$0.65-41.4%	$1.11	$1.42+37.9%	$1.03+45.1%	$0.71-52.3%	$1.49-9.7%	$1.65-9.3%	$1.82+193.5%	$0.62-62.4%	$1.65
Diluted Shares (Avg)	N/A	545M	537M	548M-1.7%	557M-1.5%	566M	541M+5.6%	512M	250M+0.4%	249M+6.0%	235M+8.0%	217M-2.8%	224M+2.7%	218M+5.8%	206M+1.1%	204M

Metric	Q1'2710-Q	Q4'2610-Q	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q	Q2'2510-Q
Revenue	$1.5B+38.0%	$1.3B+35.1%	$1.2B+15.6%	$1.1B-2.0%	$1.1B-13.4%	$970.5M-26.8%	$1.0B-41.9%	$1.2B-48.4%
Cost of Revenue	$545.8M+9.4%	$511.6M+9.0%	$479.1M+3.1%	$502.5M+1.5%	$498.8M-1.1%	$469.4M-12.4%	$464.6M-28.0%	$495.3M-31.9%
Gross Profit	$938.9M+62.8%	$799.6M+59.6%	$706.9M+25.9%	$637.9M-4.6%	$576.7M-21.7%	$501.1M-36.6%	$561.4M-49.9%	$668.5M-56.2%
R&D Expenses	$308.9M+20.9%	$293.8M+15.1%	$274.3M+11.4%	$262.3M+9.0%	$255.5M+5.7%	$255.2M+6.2%	$246.2M-7.4%	$240.7M-17.7%
SG&A Expenses	$184.3M+15.7%	$174.2M+14.6%	$168.5M+6.5%	$172.3M+9.7%	$159.3M+5.8%	$152.0M-6.1%	$158.2M-8.1%	$157.0M-20.1%
Operating Income	$336.8M+949.2%	$217.4M+316.7%	$151.7M+390.9%	$88.9M-39.4%	$32.1M-85.3%	-$100.3M-139.6%	$30.9M-94.2%	$146.6M-83.4%
EBITDA	$493.5M+142.9%	$391.1M+351.1%	$323.5M+48.6%	$261.6M-21.7%	$203.2M-50.2%	$86.7M-81.6%	$217.7M-70.9%	$334.2M-69.7%
Interest Expense	$48.8M-15.0%	$51.7M-25.7%	$55.9M-18.6%	$56.3M-4.7%	$57.4M-7.1%	$69.6M+26.3%	$68.7M+39.6%	$59.1M+26.3%
Income Tax	$60.1M+2046.4%	$19.7M+243.8%	$30.9M+312.0%	-$9.9M-175.6%	$2.8M-91.4%	-$13.7M-130.4%	$7.5M-88.5%	$13.1M-92.2%
Net Income	$229.8M+1335.5%	$144.2M+193.3%	$62.7M+217.0%	$41.7M-46.8%	-$18.6M-114.4%	-$154.6M-199.9%	-$53.6M-112.8%	$78.4M-88.2%
EPS (Basic)	$0.37+511.1%	$0.22+173.3%	$0.06+160.0%	$0.03-80.0%	-$0.09-137.5%	-$0.30-203.4%	-$0.10-112.8%	$0.15-87.8%
EPS (Diluted)	$0.37	$0.22+175.9%	$0.06	$0.03	-$0.09	-$0.29-200.0%	-$0.10-113.0%	$0.14-88.4%
Diluted Shares (Avg)	551M	N/A	546M	545M	539M	N/A	537M-1.7%	542M-1.3%

MCHPP Balance Sheet

MCHPP quarterly balance sheet

Metric	FY2610-K	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K
Total Assets	$14.4B-6.5%	$15.4B-3.1%	$15.9B-3.0%	$16.4B+1.1%	$16.2B-1.7%	$16.5B-5.4%	$17.4B-5.0%	$18.4B+122.2%	$8.3B+7.4%	$7.7B+38.8%	$5.5B+15.8%	$4.8B+17.5%	$4.1B+5.6%	$3.9B+24.9%	$3.1B
Current Assets	$2.4B-20.5%	$3.0B-0.7%	$3.0B-1.8%	$3.1B+25.1%	$2.5B+14.3%	$2.1B-3.2%	$2.2B+0.1%	$2.2B-34.0%	$3.4B+45.6%	$2.3B-25.6%	$3.1B+16.2%	$2.7B+35.3%	$2.0B-11.9%	$2.2B+10.9%	$2.0B
Cash & Equivalents	$240.3M-68.9%	$771.7M+141.4%	$319.7M+36.6%	$234.0M-26.3%	$317.4M+13.4%	$280.0M-30.2%	$401.0M-6.4%	$428.6M-52.4%	$901.3M-0.8%	$908.7M-56.6%	$2.1B+244.3%	$607.8M+30.3%	$466.6M-11.7%	$528.3M-16.9%	$635.8M
Short-Term Investments	$0	$0	$0	$0-100.0%	$2.0M0.0%	$2.0M0.0%	$2.0M-13.0%	$2.3M-99.8%	$1.3B+228.7%	$394.1M0.0%	$394.1M-70.8%	$1.4B+53.8%	$878.2M-16.4%	$1.1B+27.6%	$823.3M
Inventory	$1.0B-20.0%	$1.3B-1.7%	$1.3B-0.7%	$1.3B+55.1%	$854.4M+28.5%	$665.0M-3.0%	$685.7M-3.7%	$711.7M+49.5%	$476.2M+14.1%	$417.2M+36.0%	$306.8M+9.8%	$279.5M+6.4%	$262.7M+8.4%	$242.3M+11.5%	$217.3M
Accounts Receivable	$894.7M+29.7%	$689.7M-39.7%	$1.1B-12.4%	$1.3B+21.7%	$1.1B+7.5%	$997.7M+6.8%	$934.0M+6.1%	$880.6M+56.2%	$563.7M+17.8%	$478.4M+64.9%	$290.2M+5.9%	$273.9M+13.0%	$242.4M+5.4%	$230.0M+35.1%	$170.2M
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0-100.0%	$107.5M0.0%	$107.5M-72.0%	$383.3M-52.0%	$798.7M+210.2%	$257.4M-21.6%	$328.6M
Goodwill	$6.7B+0.2%	$6.7B+0.1%	$6.7B0.0%	$6.7B0.0%	$6.7B0.0%	$6.7B+0.1%	$6.7B0.0%	$6.7B+189.9%	$2.3B0.0%	$2.3B+127.0%	$1.0B+77.3%	$571.3M+106.9%	$276.1M+1.8%	$271.3M+190.2%	$93.5M
Total Liabilities	$7.9B-4.3%	$8.3B-10.0%	$9.2B-6.5%	$9.9B-4.3%	$10.3B-7.5%	$11.1B-5.9%	$11.8B-9.4%	$13.1B+162.4%	$5.0B+12.7%	$4.4B-20.3%	$5.5B+16.2%	$4.8B+146.9%	$1.9B+0.7%	$1.9B+75.5%	$1.1B
Current Liabilities	$1.1B-1.6%	$1.2B-54.2%	$2.5B-19.2%	$3.1B+122.9%	$1.4B-41.9%	$2.4B+47.2%	$1.6B-31.0%	$2.4B+17.7%	$2.0B+186.4%	$704.5M+84.4%	$382.0M+7.9%	$354.0M+5.3%	$336.1M-1.6%	$341.6M+37.8%	$247.9M
Non-Current Liabilities	$6.8B-4.8%	$7.1B+6.6%	$6.7B-0.6%	$6.7B-24.3%	$8.9B+2.0%	$8.7B-14.4%	$10.2B-4.5%	$10.7B+261.1%	$3.0B-20.3%	$3.7B-28.1%	$5.2B+16.8%	$4.4B+176.7%	$1.6B+1.3%	$1.6B+86.5%	$845.2M
Long-Term Debt	$5.5B-2.4%	$5.6B+12.6%	$5.0B-0.8%	$5.0B-34.4%	$7.7B+1.4%	$7.6B-14.6%	$8.9B-0.8%	$8.9B+408.8%	$1.8B-39.4%	$2.9B+18.2%	$2.5B	N/A	N/A	N/A	N/A
Total Equity	$6.4B-9.1%	$7.1B+6.3%	$6.7B+2.2%	$6.5B+10.5%	$5.9B+10.4%	$5.3B-4.4%	$5.6B+5.6%	$5.3B+61.2%	$3.3B+0.3%	$3.3B+97529.3%	-$3.4M-130.3%	$11.1M-99.5%	$2.1B+10.4%	$1.9B-2.9%	$2.0B
Retained Earnings	$4.9B-15.0%	$5.8B-14.5%	$6.8B+17.3%	$5.8B+38.1%	$4.2B+23.0%	$3.4B-1.1%	$3.4B+6.9%	$3.2B+129.8%	$1.4B-5.5%	$1.5B-6.5%	$1.6B+2.1%	$1.5B+5.6%	$1.5B+8.4%	$1.4B-9.8%	$1.5B

Metric	Q1'2710-Q	Q4'2610-Q	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q	Q2'2510-Q
Total Assets	$14.4B-3.8%	$14.4B-6.5%	$14.3B-8.4%	$14.5B-7.4%	$15.0B-5.4%	$15.4B-3.1%	$15.6B-3.2%	$15.6B-5.9%
Current Assets	$2.5B-9.7%	$2.4B-20.5%	$2.3B-23.5%	$2.4B-19.1%	$2.8B-6.6%	$3.0B-0.7%	$3.0B-7.0%	$2.9B-17.6%
Cash & Equivalents	$272.3M-51.9%	$240.3M-68.9%	$250.7M-57.2%	$236.8M-17.2%	$566.5M+79.8%	$771.7M+141.4%	$586.0M+108.5%	$286.1M+11.5%
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Inventory	$1.0B-10.4%	$1.0B-20.0%	$1.1B-22.0%	$1.1B-18.2%	$1.2B-10.6%	$1.3B-1.7%	$1.4B+3.4%	$1.3B+0.7%
Accounts Receivable	$967.7M+26.4%	$894.7M+29.7%	$731.2M-14.7%	$746.2M-28.5%	$765.5M-30.1%	$689.7M-39.7%	$857.2M-38.7%	$1.0B-38.8%
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$6.7B0.0%	$6.7B+0.2%	$6.7B+0.2%	$6.7B+0.2%	$6.7B+0.2%	$6.7B+0.1%	$6.7B+0.1%	$6.7B+0.1%
Total Liabilities	$8.0B-2.0%	$7.9B-4.3%	$7.8B-19.1%	$7.8B-16.8%	$8.1B-13.9%	$8.3B-10.0%	$9.6B+5.9%	$9.3B-3.0%
Current Liabilities	$1.3B+8.7%	$1.1B-1.6%	$1.1B-20.4%	$1.0B-68.2%	$1.2B-21.7%	$1.2B-54.2%	$1.3B-59.6%	$3.3B-3.7%
Non-Current Liabilities	$6.7B-3.9%	$6.8B-4.8%	$6.7B-18.9%	$6.7B+11.0%	$6.9B-12.4%	$7.1B+6.6%	$8.3B+43.3%	$6.1B-2.6%
Long-Term Debt	$5.4B-1.8%	$5.5B-2.4%	$5.4B-20.5%	$5.4B+20.1%	$5.5B-11.5%	$5.6B+12.6%	$6.7B+67.3%	$4.5B+1.4%
Total Equity	$6.5B-5.9%	$6.4B-9.1%	$6.6B+8.8%	$6.7B+6.7%	$6.9B+7.0%	$7.1B+6.3%	$6.0B-14.8%	$6.3B-9.9%
Retained Earnings	$4.9B-11.3%	$4.9B-15.0%	$5.0B-18.4%	$5.3B-18.9%	$5.5B-17.4%	$5.8B-14.5%	$6.2B-9.7%	$6.5B-2.8%

MCHPP Cash Flow Statement

MCHPP quarterly cash flow statement

Metric	TTM	FY2610-K	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K
Operating Cash Flow	$1.2B	$962.1M+7.1%	$898.1M-69.0%	$2.9B-20.1%	$3.6B+27.4%	$2.8B+48.3%	$1.9B+24.1%	$1.5B-7.8%	$1.7B+18.0%	$1.4B+34.0%	$1.1B+42.3%	$744.4M+3.2%	$721.2M+6.6%	$676.6M+47.3%	$459.4M+11.5%	$412.0M
Depreciation & Amortization	N/A	$689.3M-8.1%	$750.1M-14.7%	$879.5M-11.9%	$998.4M-12.7%	$1.1B-0.8%	$1.2B-5.1%	$1.2B+38.7%	$876.4M+42.3%	$615.9M+31.3%	$469.2M+65.7%	$283.2M+1.8%	$278.3M+47.1%	$189.1M-7.3%	$204.1M+105.3%	$99.4M
Stock-Based Compensation	N/A	$255.4M+41.6%	$180.4M+1.6%	$177.5M+4.2%	$170.4M-18.9%	$210.2M+6.0%	$198.3M+16.5%	$170.2M+2.3%	$166.4M+78.5%	$93.2M-27.2%	$128.1M+79.4%	$71.4M+21.9%	$58.6M+8.9%	$53.8M+3.3%	$52.1M+36.0%	$38.3M
Capital Expenditures	$87.1M	$91.1M-27.7%	$126.0M-55.8%	$285.1M-41.4%	$486.2M+31.4%	$370.1M+299.7%	$92.6M+37.0%	$67.6M-70.5%	$228.9M+10.7%	$206.8M+1927.5%	$10.2M+43.7%	$7.1M+6.6%	$6.7M-26.5%	$9.1M+91.7%	$4.7M-18.7%	$5.8M
Free Cash Flow	$1.1B	$871.0M+12.8%	$772.1M-70.4%	$2.6B-16.8%	$3.1B+26.8%	$2.5B+35.6%	$1.8B+23.6%	$1.5B+2.1%	$1.4B+19.2%	$1.2B+15.6%	$1.0B+42.3%	$737.3M+3.2%	$714.5M+7.0%	$667.5M+46.8%	$454.6M+11.9%	$406.2M
Investing Cash Flow	-$210.6M	-$195.5M+32.1%	-$287.8M+26.6%	-$392.1M+34.6%	-$599.5M-25.5%	-$477.7M-175.6%	-$173.3M-30.1%	-$133.2M+98.0%	-$6.8B-573.2%	-$1.0B+64.4%	-$2.8B-454.6%	$800.4M+218.0%	-$678.3M-34.8%	-$503.3M+47.0%	-$949.9M-249.2%	-$272.0M
Financing Cash Flow	-$1.3B	-$1.3B-720.0%	-$158.3M+93.4%	-$2.4B+22.2%	-$3.1B-33.4%	-$2.3B-24.9%	-$1.9B-29.6%	-$1.4B-130.8%	$4.7B+1222.9%	-$415.3M-169.7%	$595.5M+1094.2%	-$59.9M-160.8%	$98.5M+141.9%	-$235.0M-161.5%	$382.2M+283.6%	-$208.1M
Dividends Paid	$985.4M	$984.0M+0.9%	$975.7M+7.0%	$911.5M	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	$0-100.0%	$96.5M-90.2%	$982.1M+3.8%	$945.8M+122.2%	$425.6M	$0	$0	N/A	$0	$0-100.0%	$363.8M	$0	$0	N/A	N/A

Metric	Q1'2710-Q	Q4'2610-Q	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q	Q2'2510-Q
Operating Cash Flow	$511.5M+85.6%	$257.0M+24.8%	$341.4M+25.7%	$88.1M+102.1%	$275.6M-26.9%	$205.9M-52.1%	$271.5M-68.2%	$43.6M-92.9%
Depreciation & Amortization	$156.7M-8.4%	$173.7M-7.1%	$171.8M-8.0%	$172.7M-7.9%	$171.1M-9.3%	$187.0M-14.3%	$186.8M-14.9%	$187.6M-14.3%
Stock-Based Compensation	$75.0M+41.8%	N/A	$72.6M+47.0%	$61.6M+33.0%	$52.9M+20.2%	N/A	$49.4M+10.3%	$46.3M+2.0%
Capital Expenditures	$13.9M-22.3%	$14.2M0.0%	$22.5M+24.3%	$36.5M+75.5%	$17.9M-75.4%	$14.2M-64.6%	$18.1M-69.6%	$20.8M-72.0%
Free Cash Flow	$497.6M+93.1%	$242.8M+26.7%	$318.9M+25.8%	$51.6M+126.3%	$257.7M-15.3%	$191.7M-50.8%	$253.4M-68.1%	$22.8M-95.8%
Investing Cash Flow	-$52.0M-40.9%	-$52.1M+7.0%	-$44.5M-5.7%	-$62.0M+3.4%	-$36.9M+70.6%	-$56.0M+21.3%	-$42.1M+51.2%	-$64.2M+31.6%
Financing Cash Flow	-$427.5M+3.7%	-$215.3M-701.4%	-$283.0M-501.4%	-$355.8M-4135.7%	-$443.9M-73.3%	$35.8M+111.2%	$70.5M+109.5%	-$8.4M+98.4%
Dividends Paid	$246.9M+0.6%	$246.6M+0.7%	$246.1M+0.6%	$245.8M+0.9%	$245.5M+1.2%	$244.8M	$244.6M	$243.7M
Share Buybacks	N/A	$0	$0-100.0%	$0-100.0%	$0-100.0%	$0-100.0%	$6.5M-94.3%	$17.3M-94.9%

MCHPP Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

MCHPP quarterly financial ratios

Metric	FY2610-K	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K
Gross Margin	57.7%+1.7pp	56.1%-9.4pp	65.4%-2.1pp	67.5%+2.3pp	65.2%+3.1pp	62.1%+0.7pp	61.5%+6.7pp	54.8%-6.0pp	60.8%+9.3pp	51.6%-3.9pp	55.5%-1.8pp	57.3%-1.2pp	58.5%+5.4pp	53.0%-4.8pp	57.8%
Operating Margin	10.4%+3.7pp	6.7%-26.9pp	33.7%-3.3pp	36.9%+9.8pp	27.1%+8.8pp	18.4%+6.1pp	12.3%-1.1pp	13.4%-10.2pp	23.5%+15.4pp	8.1%-8.1pp	16.2%-3.6pp	19.8%-3.9pp	23.8%+12.5pp	11.3%-17.4pp	28.7%
Net Margin	4.9%+4.9pp	0.0%-25.0pp	25.0%-1.5pp	26.5%+7.7pp	18.9%+12.4pp	6.4%-4.4pp	10.8%+4.2pp	6.7%+0.2pp	6.4%+1.6pp	4.8%-10.1pp	14.9%-2.3pp	17.2%-3.3pp	20.5%+12.4pp	8.1%-16.3pp	24.3%
Return on Equity	3.6%+3.6pp	0.0%-28.6pp	28.6%-5.7pp	34.4%+12.5pp	21.8%+15.3pp	6.6%-3.7pp	10.2%+3.5pp	6.7%-1.1pp	7.8%+2.8pp	5.0%	N/A	3331.6%+3313.1pp	18.5%+11.9pp	6.6%-10.3pp	16.9%
Return on Assets	1.6%+1.6pp	0.0%-12.0pp	12.0%-1.7pp	13.7%+5.7pp	7.9%+5.8pp	2.1%-1.1pp	3.3%+1.3pp	1.9%-1.1pp	3.1%+1.0pp	2.1%-3.7pp	5.9%-1.9pp	7.7%-2.0pp	9.7%+6.4pp	3.3%-7.6pp	10.9%
Current Ratio	2.09-0.5x	2.59+1.4x	1.20+0.2x	0.98-0.8x	1.75+0.9x	0.89-0.5x	1.35+0.4x	0.93-0.7x	1.66-1.6x	3.27-4.8x	8.11+0.6x	7.53+1.7x	5.86-0.7x	6.55-1.6x	8.13
Debt-to-Equity	0.85+0.1x	0.800.0x	0.750.0x	0.77-0.5x	1.30-0.1x	1.42-0.2x	1.59-0.1x	1.69+1.2x	0.54-0.4x	0.89	N/A	430.63+429.7x	0.90-0.1x	0.99+0.4x	0.55
Asset Turnover	0.330.0x	0.29-0.2x	0.480.0x	0.52+0.1x	0.42+0.1x	0.330.0x	0.300.0x	0.29-0.2x	0.480.0x	0.44+0.1x	0.39-0.1x	0.450.0x	0.47+0.1x	0.410.0x	0.45
FCF Margin	18.5%+0.9pp	17.5%-16.6pp	34.2%-3.0pp	37.1%+0.9pp	36.3%+2.7pp	33.5%+5.5pp	28.0%+1.0pp	27.0%-3.4pp	30.5%-0.3pp	30.8%-3.1pp	33.9%+0.7pp	33.3%-1.3pp	34.6%+5.8pp	28.7%-0.6pp	29.4%

Metric	Q1'2710-Q	Q4'2610-Q	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q	Q2'2510-Q
Gross Margin	63.2%+9.6pp	61.0%+9.4pp	59.6%+4.9pp	55.9%-1.5pp	53.6%-5.8pp	51.6%-8.0pp	54.7%-8.7pp	57.4%-10.3pp
Operating Margin	22.7%+19.7pp	16.6%+26.9pp	12.8%+9.8pp	7.8%-4.8pp	3.0%-14.7pp	-10.3%-29.4pp	3.0%-27.0pp	12.6%-26.7pp
Net Margin	15.5%+17.2pp	11.0%+26.9pp	5.3%+10.5pp	3.7%-3.1pp	-1.7%-12.2pp	-15.9%-27.6pp	-5.2%-29.0pp	6.7%-22.8pp
Return on Equity	3.6%+3.8pp	2.2%+4.4pp	1.0%+1.8pp	0.6%-0.6pp	-0.3%-2.3pp	-2.2%-4.5pp	-0.9%-6.8pp	1.3%-8.3pp
Return on Assets	1.6%+1.7pp	1.0%+2.0pp	0.4%+0.8pp	0.3%-0.2pp	-0.1%-0.9pp	-1.0%-2.0pp	-0.3%-2.9pp	0.5%-3.5pp
Current Ratio	1.92-0.4x	2.09-0.5x	2.16-0.1x	2.25+1.4x	2.31+0.4x	2.59+1.4x	2.25+1.3x	0.88-0.1x
Debt-to-Equity	0.830.0x	0.85+0.1x	0.82-0.3x	0.80+0.1x	0.80-0.2x	0.800.0x	1.12+0.5x	0.71+0.1x
Asset Turnover	0.100.0x	0.090.0x	0.080.0x	0.080.0x	0.070.0x	0.060.0x	0.070.0x	0.07-0.1x
FCF Margin	33.5%+9.6pp	18.5%-1.2pp	26.9%+2.2pp	4.5%+2.6pp	24.0%-0.6pp	19.8%-9.7pp	24.7%-20.3pp	2.0%-22.1pp

Where MICROCHIP TECHNOLOGY INC. Ranks

Frequently Asked Questions

What is MICROCHIP TECHNOLOGY INC.'s annual revenue?

MICROCHIP TECHNOLOGY INC. (MCHPP) reported $4.7B in total revenue for fiscal year 2026. This represents a 7.1% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is MICROCHIP TECHNOLOGY INC.'s revenue growing?

MICROCHIP TECHNOLOGY INC. (MCHPP) revenue grew by 7.1% year-over-year, from $4.4B to $4.7B in fiscal year 2026.

Is MICROCHIP TECHNOLOGY INC. profitable?

Yes, MICROCHIP TECHNOLOGY INC. (MCHPP) reported a net income of $230.0M in fiscal year 2026, with a net profit margin of 4.9%.

What is MICROCHIP TECHNOLOGY INC.'s EBITDA?

MICROCHIP TECHNOLOGY INC. (MCHPP) had EBITDA of $1.2B in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does MICROCHIP TECHNOLOGY INC. have?

As of fiscal year 2026, MICROCHIP TECHNOLOGY INC. (MCHPP) had $240.3M in cash and equivalents against $5.5B in long-term debt.

What is MICROCHIP TECHNOLOGY INC.'s gross margin?

MICROCHIP TECHNOLOGY INC. (MCHPP) had a gross margin of 57.7% in fiscal year 2026, indicating the percentage of revenue retained after direct costs of goods sold.

What is MICROCHIP TECHNOLOGY INC.'s operating margin?

MICROCHIP TECHNOLOGY INC. (MCHPP) had an operating margin of 10.4% in fiscal year 2026, reflecting the profitability of core business operations before interest and taxes.

What is MICROCHIP TECHNOLOGY INC.'s net profit margin?

MICROCHIP TECHNOLOGY INC. (MCHPP) had a net profit margin of 4.9% in fiscal year 2026, representing the share of revenue converted into profit after all expenses.

Does MICROCHIP TECHNOLOGY INC. pay dividends?

Yes, MICROCHIP TECHNOLOGY INC. (MCHPP) paid $1.82 per share in dividends during fiscal year 2026.

What is MICROCHIP TECHNOLOGY INC.'s return on equity (ROE)?

MICROCHIP TECHNOLOGY INC. (MCHPP) has a return on equity of 3.6% for fiscal year 2026, measuring how efficiently the company generates profit from shareholder equity.

What is MICROCHIP TECHNOLOGY INC.'s free cash flow?

MICROCHIP TECHNOLOGY INC. (MCHPP) generated $871.0M in free cash flow during fiscal year 2026. This represents a 12.8% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is MICROCHIP TECHNOLOGY INC.'s operating cash flow?

MICROCHIP TECHNOLOGY INC. (MCHPP) generated $962.1M in operating cash flow during fiscal year 2026, representing cash generated from core business activities.

What are MICROCHIP TECHNOLOGY INC.'s total assets?

MICROCHIP TECHNOLOGY INC. (MCHPP) had $14.4B in total assets as of fiscal year 2026, including both current and long-term assets.

What are MICROCHIP TECHNOLOGY INC.'s capital expenditures?

MICROCHIP TECHNOLOGY INC. (MCHPP) invested $91.1M in capital expenditures during fiscal year 2026, funding long-term assets and infrastructure.

How much does MICROCHIP TECHNOLOGY INC. spend on research and development?

MICROCHIP TECHNOLOGY INC. (MCHPP) invested $1.1B in research and development during fiscal year 2026.

How many shares does MICROCHIP TECHNOLOGY INC. have outstanding?

MICROCHIP TECHNOLOGY INC. (MCHPP) had 542M shares outstanding as of fiscal year 2026.

What is MICROCHIP TECHNOLOGY INC.'s current ratio?

MICROCHIP TECHNOLOGY INC. (MCHPP) had a current ratio of 2.09 as of fiscal year 2026, which is generally considered healthy.

What is MICROCHIP TECHNOLOGY INC.'s debt-to-equity ratio?

MICROCHIP TECHNOLOGY INC. (MCHPP) had a debt-to-equity ratio of 0.85 as of fiscal year 2026, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is MICROCHIP TECHNOLOGY INC.'s return on assets (ROA)?

MICROCHIP TECHNOLOGY INC. (MCHPP) had a return on assets of 1.6% for fiscal year 2026, measuring how efficiently the company uses its assets to generate profit.

What is MICROCHIP TECHNOLOGY INC.'s Piotroski F-Score?

MICROCHIP TECHNOLOGY INC. (MCHPP) has a Piotroski F-Score of 6 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are MICROCHIP TECHNOLOGY INC.'s earnings high quality?

MICROCHIP TECHNOLOGY INC. (MCHPP) has an earnings quality ratio of 4.18x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can MICROCHIP TECHNOLOGY INC. cover its interest payments?

MICROCHIP TECHNOLOGY INC. (MCHPP) has an interest coverage ratio of 2.21x, meaning it can adequately cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.